Received Feb 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 3 | 3003183 | — |
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | 1 | ABW4330 | — |
| FLU4 | INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) | SEQIRUS, INC. | UNK | P100350740 | — |
Spondylosis with radiculopathy; Cervical area claustrophobia; Spondylosis with radiculopathy; Paralysis and dysfunction of the nervous system since vaccination/ paralysis of left hand; Parsonage-Turner syndrome; Interchange of vaccine / Revaccination with different COVID-19 vaccine; High grade C7plus 8 paresis on the left; Pain in left arm/shoulder area; This spontaneous case, initially received on 22-Jan-2026, was reported by a non health professional and concerns a patient of unknown age/gender. Medical history and concomitant medications were unknown. Administration of company suspect drug: On 02-Nov-2021, the patient received Afluria Quadrivalent for Flu vaccination, Dose regimen: 1 DF, Route of administration: Not reported, Anatomical location: Not reported, Lot number: P100350740. Non-company suspect drugs: On 17-Jul-2021, the patient received Spikevax (COVID-19 vaccine mRNA omicron (JN.1) Moderna) for COVID-19 prophylaxis, Dose regimen: 1 DF, Dose number: 2, Route of administration: Unknown, Lot number: 3003183. On 11-Dec-2021, the patient also received Spikevax, Dose regimen: 1 DF, Dose number: 3, Route of administration: Unknown, Lot number: 3004951. On 14-May-2021, the patient received Vaxzevria (COVID-19 vaccine NRVV Ad (ChAdOx1 nCoV-19)) for COVID-19 prophylaxis, Dose regimen: 1 DF, Dose number: 1, Route of administration: Unknown, Lot number: ABW4330. Adverse reactions/events and outcomes: On 17-Jul-2021, the patient experienced Interchange of vaccine / Revaccination with different COVID-19 vaccine (outcome: Unknown). On an unknown date, the patient experienced Cervical area claustrophobia (Life-threatening, outcome: Unknown), Spondylosis with radiculopathy (Life-threatening, outcome: Unknown), Paralysis and dysfunction of the nervous system since vaccination/ paralysis of left hand (Medically Significant, outcome: Not recovered / Not resolved), Spondylosis with radiculopathy (Life-threatening, outcome: Unknown), Parsonage-Turner syndrome (Medically Significant, outcome: Unknown), High grade C7plus 8 paresis on the left (outcome: Unknown), Pain in left arm/shoulder area (outcome: Not Reported). This spontaneous case was reported by an attorney and describes the occurrence of spinal osteoarthritis (Confirmed other spondylosis with radiculopathy: Cervical region/Secured other spondylosis with radiculopathy: cervical area claustrophobia severe C7+8 paresis left) and monoplegia (Patient experienced symptoms in the form of paralysis and dysfunction of the nervous system since vaccination/ paralysis of left hand) in a patient who received mRNA-1273 (Spikevax) (batch numbers 3004951 and 3003183) for COVID-19 prophylaxis. The occurrence of additional non-serious events was detailed below. Co-suspect products included non-company products COVID-19 vaccine NRVV Ad (ChAdOx1 nCoV-19) (Vaxzevria) for COVID-19 prophylaxis and Influenza vaccine inact split 4v (Afluria tetra) for Flu vaccination. No Medical History information was reported. On 14-May-2021, the patient received first dose of COVID-19 vaccine NRVV Ad (ChAdOx1 nCoV-19) (Vaxzevria) (unknown route) 1 dosage form. On 17-Jul-2021, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-Nov-2021, the patient received dose of Influenza vaccine inact split 4v (Afluria tetra) (unknown route) 1 dosage form. On 11-Dec-2021, received third dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-Jul-2021, the patient experienced interchange of vaccine products (Interchange of vaccine products) and COVID-19 immunisation (Revaccination with different COVID-19 vaccine). On an unknown date, the patient experienced spinal osteoarthritis (Confirmed other spondylosis with radiculopathy: Cervical region/Secured other spondylosis with radiculopathy: cervical area claustrophobia severe C7+8 paresis left) (seriousness criterion life threatening), monoplegia (Patient experienced symptoms in the form of paralysis and dysfunction of the nervous system since vaccination/ paralysis of left hand) (seriousness criterion medically significant), neuralgic amyotrophy (Parsonage-Turner syndrome.), claustrophobia (Claustrophobia) and paresis (High grade C7plus 8 paresis on the left). At the time of the report, spinal osteoarthritis (Confirmed other spondylosis with radiculopathy: Cervical region/Secured other spondylosis with radiculopathy: cervical area claustrophobia severe C7+8 paresis left), neuralgic amyotrophy (Parsonage-Turner syndrome.), claustrophobia (Claustrophobia), paresis (High grade C7plus 8 paresis on the left), interchange of vaccine products (Interchange of vaccine products) and COVID-19 immunisation (Revaccination with different COVID-19 vaccine) outcome was unknown and monoplegia (Patient experienced symptoms in the form of paralysis and dysfunction of the nervous system since vaccination/ paralysis of left hand) had not resolved. Concomitant medication was not reported. It was reported that before the vaccination, the patient was in good health. Patient experienced symptoms in the form of paralysis and dysfunction of the nervous system since vaccination. Diagnosis was confirmed as other spondylosis with radiculopathy, in cervical area and claustrophobia and severe C7 + 8 paresis on left side. Patient suffered from paralysis of left hand (paresis). The medical diagnosis was likely Parsonage-Turner syndrome. This significantly hindered daily work as an architect/construction manager. was no longer allowed to climb scaffolding. It started after the vaccination with pain in left arm/shoulder area, followed by paralysis of left hand. The damage was permanent. Requested for assessment and examination, if necessary, Electromyography (EMG) of C6-7-8 left. Magnetic Resonance Imaging (MRI) of cervical spine was requested preferably with open MRI if possible, for surgery indication. Treatment information was not provided. Afluria Quadrivalent action taken: Not Applicable Reporter's assessment: The primary reporter (other) assessed the events Spondylosis with radiculopathy, Cervical area claustrophobia as serious (Life-threatening), the event Paralysis and dysfunction of the nervous system since vaccination/ paralysis of left hand as serious (Medically Significant) and the events Interchange of vaccine / Revaccination with different COVID-19 vaccine, Parsonage-Turner syndrome, High grade C7plus 8 paresis on the left as non-serious. The reporter did not provide causality assessment for all events. The reporter did not provide seriousness and causality assessment for event pain in left arm/shoulder area. Case correction (22-Jan-2026): upon internal review, event dysfunction of the nervous system since vaccination, claustrophobia were removed, new event pain in left arm/shoulder area, cervical area claustrophobia were added, for event of Parsonage Turner syndrome medically significant checkbox was ticked and updated narrative accordingly.; Reporter's Comments: Due to the spontaneous nature of the case, it is considered related for reporting purposes. However, the information is insufficient (relevant medical history, concomitant medications and treatment details) to perform in-depth analysis. However cosuspect Spikevax and Vaxzevria (Covid-19) vaccines can be considered as confounders for event.